Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
44
ASTH Quote, Financials, Valuation and Earnings
Last price:
$24.7100
Seasonality move
:
58834.16%
Day range:
$24.5000 - $25.4550
52-week range:
$23.1200 - $63.2000
Dividend yield:
0%
P/E ratio:
35.11x
P/S ratio:
0.54x
P/B ratio:
1.57x
Volume:
293.5K
Avg. volume:
264.6K
1-year change:
-50.38%
Market cap:
$1.2B
Revenue:
$2B
EPS (TTM):
$0.72
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $370.2M | $773.9M | $1.1B | $1.4B | $2B | |
| Revenue Growth (YoY) | -33.96% | 109.03% | 47.84% | 21.19% | 46.72% | |
| Cost of Revenues | $348.5M | $596.1M | $944.7M | $1.2B | $1.8B | |
| Gross Profit | $21.7M | $177.8M | $199.5M | $215M | $271.4M | |
| Gross Profit Margin | 5.86% | 22.97% | 17.43% | 15.5% | 13.34% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $15.6M | $62.1M | $77.7M | $112.6M | $154.1M | |
| Other Inc / (Exp) | $4.9M | -$16.6M | -$11.7M | $7.1M | $10.1M | |
| Operating Expenses | $15.6M | $79.6M | $95.2M | $130.3M | $182M | |
| Operating Income | $6.1M | $98.2M | $104.3M | $84.6M | $89.4M | |
| Net Interest Expenses | $2.1M | $3.8M | $5.9M | $1.9M | $18.6M | |
| EBT. Incl. Unusual Items | $8.9M | $77.7M | $86.6M | $89.8M | $80.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.2M | $31.7M | $40.9M | $32M | $30.9M | |
| Net Income to Company | $122.1M | $46.1M | $45.7M | $57.8M | $49.9M | |
| Minority Interest in Earnings | -$23.4M | $22.9M | -$570K | $2.9M | -$6.8M | |
| Net Income to Common Excl Extra Items | -$23.8M | $68.9M | $45.2M | $60.7M | $43.1M | |
| Basic EPS (Cont. Ops) | -$1.03 | $1.57 | $1.00 | $1.30 | $0.91 | |
| Diluted EPS (Cont. Ops) | -$1.03 | $1.52 | $0.99 | $1.29 | $0.90 | |
| Weighted Average Basic Share | $36.5M | $43.8M | $45M | $46.6M | $47.6M | |
| Weighted Average Diluted Share | $37.4M | $45.4M | $45.6M | $46.9M | $48M | |
| EBITDA | $29.7M | $100.7M | $112.1M | $123.7M | $141.8M | |
| EBIT | $11.4M | $83.1M | $94.5M | $105.9M | $113.9M | |
| Revenue (Reported) | $370.2M | $773.9M | $1.1B | $1.4B | $2B | |
| Operating Income (Reported) | $6.1M | $98.2M | $104.3M | $84.6M | $89.4M | |
| Operating Income (Adjusted) | $11.4M | $83.1M | $94.5M | $105.9M | $113.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $176.1M | $263.3M | $337.2M | $404.4M | $620.4M | |
| Revenue Growth (YoY) | 6.63% | 49.53% | 28.1% | 19.9% | 53.43% | |
| Cost of Revenues | $140.6M | $220.7M | $289.4M | $330.4M | $549.1M | |
| Gross Profit | $35.4M | $42.5M | $47.8M | $74M | $71.3M | |
| Gross Profit Margin | 20.13% | 16.16% | 14.19% | 18.29% | 11.5% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $9.5M | $11.9M | $21.2M | $38.7M | $43.9M | |
| Other Inc / (Exp) | $627K | -$6.9M | -$2.7M | -$2.5M | -$6M | |
| Operating Expenses | $13.7M | $16.3M | $25.5M | $43.8M | $50.7M | |
| Operating Income | $21.8M | $26.2M | $22.4M | $30.1M | $20.6M | |
| Net Interest Expenses | $1.2M | $1M | $260K | $3.6M | $5M | |
| EBT. Incl. Unusual Items | $21.2M | $18.3M | $19.4M | $24M | $9.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.8M | $6.8M | $6.9M | $7.1M | $3.4M | |
| Net Income to Company | $14.5M | $11.5M | $12.5M | $16.9M | $6.2M | |
| Minority Interest in Earnings | -$1.3M | $2.3M | $644K | -$2M | $471K | |
| Net Income to Common Excl Extra Items | $13.2M | $13.8M | $13.1M | $14.8M | $6.7M | |
| Basic EPS (Cont. Ops) | $0.31 | $0.31 | $0.28 | $0.31 | $0.14 | |
| Diluted EPS (Cont. Ops) | $0.30 | $0.30 | $0.28 | $0.31 | $0.14 | |
| Weighted Average Basic Share | $42.3M | $44.7M | $46.6M | $47.3M | $48.5M | |
| Weighted Average Diluted Share | $43.6M | $46M | $47M | $47.7M | $48.9M | |
| EBITDA | $27M | $23.7M | $27M | $36.7M | $23.8M | |
| EBIT | $22.8M | $19.3M | $22.7M | $31.6M | $16.9M | |
| Revenue (Reported) | $176.1M | $263.3M | $337.2M | $404.4M | $620.4M | |
| Operating Income (Reported) | $21.8M | $26.2M | $22.4M | $30.1M | $20.6M | |
| Operating Income (Adjusted) | $22.8M | $19.3M | $22.7M | $31.6M | $16.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $381.2M | $861.1M | $1.2B | $1.5B | $2.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $345M | $676.3M | $1B | $1.2B | $2B | |
| Gross Profit | $36.2M | $184.9M | $204.8M | $241.1M | $268.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $13.2M | $64.6M | $86.9M | $130.1M | $159.3M | |
| Other Inc / (Exp) | $3.4M | -$24.1M | -$7.5M | $7.3M | $6.6M | |
| Operating Expenses | $12.7M | $82.3M | $104.4M | $148.7M | $189M | |
| Operating Income | $23.5M | $102.6M | $100.4M | $92.4M | $79.8M | |
| Net Interest Expenses | $1.4M | $3.7M | $5.2M | $5.2M | $20M | |
| EBT. Incl. Unusual Items | $25.5M | $74.8M | $87.8M | $94.4M | $66.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $14.4M | $31.7M | $41M | $32.2M | $27.1M | |
| Net Income to Company | $133.6M | $43M | $46.8M | $62.2M | $39.3M | |
| Minority Interest in Earnings | -$25.8M | $26.5M | -$2.2M | $197K | -$4.3M | |
| Net Income to Common Excl Extra Items | -$14.7M | $69.5M | $44.5M | $62.4M | $35M | |
| Basic EPS (Cont. Ops) | $1.25 | $1.68 | $1.01 | $1.32 | $0.73 | |
| Diluted EPS (Cont. Ops) | $1.21 | $1.62 | $0.98 | $1.32 | $0.72 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $44.5M | $97.4M | $115.3M | $133.4M | $128.9M | |
| EBIT | $26.7M | $79.7M | $97.9M | $114.9M | $99.2M | |
| Revenue (Reported) | $381.2M | $861.1M | $1.2B | $1.5B | $2.3B | |
| Operating Income (Reported) | $23.5M | $102.6M | $100.4M | $92.4M | $79.8M | |
| Operating Income (Adjusted) | $26.7M | $79.7M | $97.9M | $114.9M | $99.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $176.1M | $263.3M | $337.2M | $404.4M | $620.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $140.6M | $220.7M | $289.4M | $330.4M | $549.1M | |
| Gross Profit | $35.4M | $42.5M | $47.8M | $74M | $71.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $9.5M | $11.9M | $21.2M | $38.7M | $43.9M | |
| Other Inc / (Exp) | $627K | -$6.9M | -$2.7M | -$2.5M | -$6M | |
| Operating Expenses | $13.7M | $16.3M | $25.5M | $43.8M | $50.7M | |
| Operating Income | $21.8M | $26.2M | $22.4M | $30.1M | $20.6M | |
| Net Interest Expenses | $1.2M | $1M | $260K | $3.6M | $5M | |
| EBT. Incl. Unusual Items | $21.2M | $18.3M | $19.4M | $24M | $9.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.8M | $6.8M | $6.9M | $7.1M | $3.4M | |
| Net Income to Company | $14.5M | $11.5M | $12.5M | $16.9M | $6.2M | |
| Minority Interest in Earnings | -$1.3M | $2.3M | $644K | -$2M | $471K | |
| Net Income to Common Excl Extra Items | $13.2M | $13.8M | $13.1M | $14.8M | $6.7M | |
| Basic EPS (Cont. Ops) | $0.31 | $0.31 | $0.28 | $0.31 | $0.14 | |
| Diluted EPS (Cont. Ops) | $0.30 | $0.30 | $0.28 | $0.31 | $0.14 | |
| Weighted Average Basic Share | $42.3M | $44.7M | $46.6M | $47.3M | $48.5M | |
| Weighted Average Diluted Share | $43.6M | $46M | $47M | $47.7M | $48.9M | |
| EBITDA | $27M | $23.7M | $27M | $36.7M | $23.8M | |
| EBIT | $22.8M | $19.3M | $22.7M | $31.6M | $16.9M | |
| Revenue (Reported) | $176.1M | $263.3M | $337.2M | $404.4M | $620.4M | |
| Operating Income (Reported) | $21.8M | $26.2M | $22.4M | $30.1M | $20.6M | |
| Operating Income (Adjusted) | $22.8M | $19.3M | $22.7M | $31.6M | $16.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $193.5M | $233.1M | $288M | $293.8M | $288.5M | |
| Short Term Investments | $67.7M | $53.4M | $5.6M | $2.5M | $2.4M | |
| Accounts Receivable, Net | $7.1M | $10.6M | $49.6M | $76.8M | $225.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $16.8M | $18.6M | $14.8M | $17.5M | $22.9M | |
| Total Current Assets | $338.6M | $404.5M | $428.1M | $461.5M | $638.5M | |
| Property Plant And Equipment | $48.5M | $68.6M | $129M | $44.6M | $46.9M | |
| Long-Term Investments | $80.4M | $42.6M | $42.7M | $32.2M | $48.2M | |
| Goodwill | $239.1M | $246.4M | $269.1M | $278.8M | $419.3M | |
| Other Intangibles | $87M | $82.8M | $76.9M | $71.6M | $118.2M | |
| Other Long-Term Assets | $19.4M | $5.9M | $4.6M | $2.2M | $16.7M | |
| Total Assets | $817.5M | $867.4M | $966.2M | $933.4M | $1.4B | |
| Accounts Payable | $9.6M | $5.5M | $10.5M | $9.1M | $15.2M | |
| Accrued Expenses | $1.4M | $878K | $2.7M | $4.4M | $5.8M | |
| Current Portion Of Long-Term Debt | $10.9M | $780K | $619K | $19.5M | $9.4M | |
| Current Portion Of Capital Lease Obligations | $3.3M | $3.1M | $4.2M | $5.3M | $5.9M | |
| Other Current Liabilities | $50.3M | $55.8M | $81.3M | $125.6M | $235.3M | |
| Total Current Liabilities | $115M | $114.7M | $148.6M | $218.7M | $365.6M | |
| Long-Term Debt | $230.2M | $182.9M | $203.4M | $258.9M | $425.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $372.3M | $356.7M | $407.7M | $522.6M | $840.7M | |
| Common Stock | $42K | $45K | $47K | $47K | $48K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $330.8M | $448.2M | $542.6M | $614.2M | $712.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $114.3M | $62.5M | $16M | -$203.5M | -$198.6M | |
| Total Equity | $445.1M | $510.6M | $558.5M | $410.8M | $514.2M | |
| Total Liabilities and Equity | $817.5M | $867.4M | $966.2M | $933.4M | $1.4B | |
| Cash and Short Terms | $261.2M | $286.5M | $293.6M | $296.3M | $290.8M | |
| Total Debt | $241.1M | $183.7M | $204M | $278.4M | $434.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $205.9M | $237.9M | $274.6M | $334.8M | $258.5M | |
| Short Term Investments | $66.9M | $42.9M | $4.1M | $2.5M | $2.4M | |
| Accounts Receivable, Net | $16.4M | $55.3M | $79M | $120.1M | $241.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $9.6M | $14.6M | $22.2M | $17.3M | $23.7M | |
| Total Current Assets | $370.3M | $444.4M | $457.7M | $538.8M | $613.3M | |
| Property Plant And Equipment | $47.3M | $85.1M | $131.8M | $47.1M | $47.5M | |
| Long-Term Investments | $79.7M | $45.3M | $44M | $42.3M | $46.9M | |
| Goodwill | $239.1M | $252.4M | $276M | $410.3M | $416.4M | |
| Other Intangibles | $83.2M | $80.1M | $77.7M | $119.7M | $111.9M | |
| Other Long-Term Assets | $19.1M | $4.4M | $5.4M | $4.7M | $31.2M | |
| Total Assets | $843.3M | $912.3M | $992.6M | $1.2B | $1.3B | |
| Accounts Payable | $9.5M | $9.9M | $13.9M | $84.9M | $14.9M | |
| Accrued Expenses | $1.6M | $900K | $2.4M | $5.3M | $3.5M | |
| Current Portion Of Long-Term Debt | $12.1M | $1.5M | $621K | $20.8M | $12.5M | |
| Current Portion Of Capital Lease Obligations | $3.1M | $3.2M | $3.8M | $5.6M | $5.5M | |
| Other Current Liabilities | $51.5M | $95.8M | $101.4M | $168.5M | $232.3M | |
| Total Current Liabilities | $126.3M | $160.4M | $165M | $355.3M | $361.3M | |
| Long-Term Debt | $226.9M | $183.1M | $204.9M | $368.4M | $403.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $378.7M | $380.7M | $414.7M | $773.9M | $813.6M | |
| Common Stock | $43K | $45K | $47K | $48K | $49K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $115.4M | $57.7M | $17.9M | -$201.1M | -$227.7M | |
| Total Equity | $464.5M | $531.7M | $577.9M | $452.4M | $517.7M | |
| Total Liabilities and Equity | $843.3M | $912.3M | $992.6M | $1.2B | $1.3B | |
| Cash and Short Terms | $272.8M | $280.8M | $278.7M | $337.3M | $260.9M | |
| Total Debt | $239M | $184.6M | $205.6M | $389.2M | $416.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $122.1M | $46.1M | $45.7M | $57.8M | $49.9M | |
| Depreciation & Amoritzation | $18.4M | $17.5M | $17.5M | $17.7M | $27.9M | |
| Stock-Based Compensation | $3.4M | $6.7M | $16.1M | $22M | $34.5M | |
| Change in Accounts Receivable | $15.6M | -$27M | -$25.8M | -$20.3M | -$11.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $46.2M | $70.3M | $82.1M | $68.2M | $52.2M | |
| Capital Expenditures | $1.2M | $19.2M | $22.9M | $28.5M | $8M | |
| Cash Acquisitions | $31.4M | -$3.9M | -$18.5M | -$7.5M | -$156.1M | |
| Cash From Investing | $95.5M | $16.5M | -$7.1M | -$65.5M | -$192.4M | |
| Dividends Paid (Ex Special Dividend) | -$51.3M | -$31.1M | -$14M | -$62.1M | -$4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $180.6M | $3.6M | $284.5M | $171.9M | |
| Long-Term Debt Repaid | -$9.6M | -$238.5M | -$4.4M | -$205.4M | -$19.2M | |
| Repurchase of Common Stock | -$537K | -$5.7M | -$9.3M | -$10.2M | -$937K | |
| Other Financing Activities | -$1M | -$2.2M | -$4.6M | -$5M | -$13.6M | |
| Cash From Financing | -$51.7M | -$47.7M | -$20.1M | $3.4M | $135.1M | |
| Beginning Cash (CF) | $104M | $194M | $233.1M | $288M | $294.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $90M | $39.1M | $54.9M | $6.1M | -$5.1M | |
| Ending Cash (CF) | $194M | $233.1M | $288M | $294.2M | $289.1M | |
| Levered Free Cash Flow | $45M | $51.1M | $59.2M | $39.7M | $44.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14.5M | $11.5M | $12.5M | $16.9M | $6.2M | |
| Depreciation & Amoritzation | $4.2M | $4.4M | $4.3M | $5.1M | $6.8M | |
| Stock-Based Compensation | $1.3M | $3.1M | $3.4M | $5.7M | $7.8M | |
| Change in Accounts Receivable | -$27.2M | -$55.2M | -$36.2M | -$16.4M | -$9.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10M | $24M | $7.7M | $6M | $16.6M | |
| Capital Expenditures | $98K | $17.5M | $14.9M | $369K | $3.1M | |
| Cash Acquisitions | -- | -$2.4M | -$325K | -$50.6M | -- | |
| Cash From Investing | $692K | -$19.7M | -$14M | -$71M | -$2.4M | |
| Dividends Paid (Ex Special Dividend) | -$4K | -$1.2M | -$120K | -$95K | -$5.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $722K | $1.6M | $110M | $412M | |
| Long-Term Debt Repaid | -$2.5M | -$193K | -$307K | -$3.7M | -$428.4M | |
| Repurchase of Common Stock | -$342K | -$230K | -$9.5M | -- | -$1.3M | |
| Other Financing Activities | -$187K | -$162K | -- | $125K | -$21.3M | |
| Cash From Financing | $1.3M | $532K | -$7.1M | $106.4M | -$44.2M | |
| Beginning Cash (CF) | $194M | $233.1M | $288M | $294.2M | $289.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $11.9M | $4.8M | -$13.4M | $41.3M | -$29.9M | |
| Ending Cash (CF) | $205.9M | $237.9M | $274.6M | $335.4M | $259.2M | |
| Levered Free Cash Flow | $9.9M | $6.5M | -$7.1M | $5.6M | $13.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $133.6M | $43M | $46.8M | $62.2M | $39.3M | |
| Depreciation & Amoritzation | $17.8M | $17.7M | $17.5M | $18.6M | $29.7M | |
| Stock-Based Compensation | $3.7M | $8.5M | $16.5M | $24.3M | $36.6M | |
| Change in Accounts Receivable | -$2.3M | -$54.9M | -$6.8M | -$423K | -$4.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $65.4M | $84.4M | $65.8M | $66.5M | $62.8M | |
| Capital Expenditures | $993K | $36.6M | $20.3M | $14M | $10.7M | |
| Cash Acquisitions | $31.7M | -$6.3M | -$16.3M | -$57.9M | -$105.5M | |
| Cash From Investing | $97.1M | -$3.9M | -$1.4M | -$122.5M | -$123.8M | |
| Dividends Paid (Ex Special Dividend) | -$41.4M | -$32.3M | -$13M | -$62M | -$9.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $181.3M | $4.5M | $392.9M | $473.9M | |
| Long-Term Debt Repaid | -$9.7M | -$236.3M | -$4.5M | -$208.7M | -$443.9M | |
| Repurchase of Common Stock | -$453K | -$5.6M | -$18.6M | -$653K | -$2.3M | |
| Other Financing Activities | -- | -$2.1M | -- | -$4.9M | -$35.1M | |
| Cash From Financing | -$38.4M | -$48.5M | -$27.7M | $116.9M | -$15.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $124.2M | $32.1M | $36.7M | $60.8M | -$76.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $64.4M | $47.8M | $45.5M | $52.4M | $52.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14.5M | $11.5M | $12.5M | $16.9M | $6.2M | |
| Depreciation & Amoritzation | $4.2M | $4.4M | $4.3M | $5.1M | $6.8M | |
| Stock-Based Compensation | $1.3M | $3.1M | $3.4M | $5.7M | $7.8M | |
| Change in Accounts Receivable | -$27.2M | -$55.2M | -$36.2M | -$16.4M | -$9.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10M | $24M | $7.7M | $6M | $16.6M | |
| Capital Expenditures | $98K | $17.5M | $14.9M | $369K | $3.1M | |
| Cash Acquisitions | -- | -$2.4M | -$325K | -$50.6M | -- | |
| Cash From Investing | $692K | -$19.7M | -$14M | -$71M | -$2.4M | |
| Dividends Paid (Ex Special Dividend) | -$4K | -$1.2M | -$120K | -$95K | -$5.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $722K | $1.6M | $110M | $412M | |
| Long-Term Debt Repaid | -$2.5M | -$193K | -$307K | -$3.7M | -$428.4M | |
| Repurchase of Common Stock | -$342K | -$230K | -$9.5M | -- | -$1.3M | |
| Other Financing Activities | -$187K | -$162K | -- | $125K | -$21.3M | |
| Cash From Financing | $1.3M | $532K | -$7.1M | $106.4M | -$44.2M | |
| Beginning Cash (CF) | $194M | $233.1M | $288M | $294.2M | $289.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $11.9M | $4.8M | -$13.4M | $41.3M | -$29.9M | |
| Ending Cash (CF) | $205.9M | $237.9M | $274.6M | $335.4M | $259.2M | |
| Levered Free Cash Flow | $9.9M | $6.5M | -$7.1M | $5.6M | $13.6M | |
Get ASTH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ASTH
Sector
P/E ratio
35.11x
23.88x
PEG ratio
0.78x
0.00x
P/B ratio
1.57x
1.80x
Price / LTM sales
0.54x
1.65x
Growth Metrics
ASTH
Sector
Revenue growth
53.43%
4.06%
Earnings growth
-54.84%
7.46%
Revenue (5-year growth)
29.41%
8.01%
Earnings forecast
$0.48
-$0.20
Profitability
ASTH
Sector
Profitability FY 2024
$271.4M
$47.5M
Return on invested capital
3.81%
-16.26%
Return on assets
2.71%
-13.27%
Return on equity
7.09%
-18.61%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
7
Balance Sheet
ASTH
Sector
Total cash
$260.9M
$35.5M
Short term investments
$2.4M
$29.7M
Total assets
$1.4B
$106.9M
Long term debt
$416.4M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
